Concepedia

Olaf van Tellingen

OV

3

Publications

124

Citations

3

H-Index

1994

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Slotervaartziekenhuis

Olaf van Tellingen is an author at The Netherlands Cancer Institute specializing in cancer therapeutics, biostatistics, and drug discovery.

Top concepts

Publications per year

1994–2000

3

Publications

3

The Role of mdr1a P-Glycoprotein in the Biliary and Intestinal Secretion of Doxorubicin and Vinblastine in Mice

Judith van Asperen, Olaf van Tellingen, Jos H. Beijnen · Drug Metabolism and Disposition · 2000 · 89 citations

Validation of a limited sampling model for carboplatin in a high-dose chemotherapy combination

L.J.C. van Warmerdam, Sjoerd Rodenhuis, Olaf van Tellingen et al. · Cancer Chemotherapy and Pharmacology · 1994 · 24 citations

, , +8

Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol®) and carboplatin in non-small cell lung cancer patients

Jetske M. Meerum Terwogt, Olaf van Tellingen, Vinodh R. Nannan Panday et al. · Anti-Cancer Drugs · 2000 · 11 citations

Rows per page

1–3 of 3